Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In our conference of 2017, we assessed the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.
There are still factors like manufacturing maze, investment, logistics and regulatory challenges that prevent the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 2nd Annual MarketsandMarkets Cell & Gene Therapy Bioprocessing Online Conference. Learn from the leading experts of the industry about strategies, technologies, and innovations in the area of bioprocessing of cell-gene therapies.
Due to growing concerns about COVID-19, the event is going fully virtual this year. We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 25th & 26th June 2020. Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.
From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:
Engineers/ Scientists/ Researchers/ Project leaders in: